EC Number   |
Title   |
Organism   |
|---|
 3.4.24.24 | A novel series of highly selective inhibitors of MMP-3 |
Homo sapiens |
 3.4.24.24 | A residue in the S2 subsite controls substrate selectivity of matrix metalloproteinase-2 and matrix metalloproteinase-9 |
Homo sapiens |
 3.4.24.24 | A theoretical model of type I collagen proteolysis by matrix metalloproteinase (MMP) 2 and membrane type 1 MMP in the presence of tissue inhibitor of metalloproteinase 2 |
synthetic construct |
 3.4.24.24 | A unique substrate recognition profile for matrix metalloproteinase-2 |
Homo sapiens |
 3.4.24.24 | Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2) |
Homo sapiens |
 3.4.24.24 | Activity of matrix metalloproteinase 2 and 9 isoforms in sputum samples from individuals infected with M. tuberculosis |
Homo sapiens |
 3.4.24.24 | Activity of matrix metalloproteinase-2 (MMP-2) in canine oronasal tumors |
Canis lupus familiaris |
 3.4.24.24 | Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium |
Homo sapiens |
 3.4.24.24 | Activity of ternary gelatinase A-TIMP-2-matrix metallo-proteinase complexes |
Oryctolagus cuniculus |
 3.4.24.24 | Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats |
Homo sapiens |